SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
DiscoverWST
HealthcareNYSEUSD

West Pharmaceutical

$001234567890012345678900123456789.0012345678900123456789+10.0%
52w low (est.) $283.45$463.18 52w high (est.)
Peers
Market data
Market cap
$24.99B
52-week range
$206.80 – $367.66
Beta (vs market)
1.16
Sector
Healthcare
Valuation
P/E ratio
47.4x
DCF fair value
$287.21
Margin of safety
-20.8%
Forward P/E
37.0x
PEG ratio
3.40
Dividend yield
0.25%
Quality & efficiency
Moat score
67/100
Return on equity
19.1%
Profit margin
16.8%
Debt / equity
0.11
Growth & analysts
Revenue growth (YoY)
+21.0%
Analyst target
$365.93
Target upside
+1.0%
Analysts covering
14

About West Pharmaceutical

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Valuation

ValueGrowthProfitHealthIncome52QUALITY
Overall Rating
47
Hold
Hold
Moat Score67
DCF Intrinsic Value
$287.21-20.8% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$24.99B
P/E Ratio
47.4
Dividend Yield
0.25%
Revenue Growth
+21.0%
Profit Margin
16.8%
ROE
19.1%
Debt / Equity
0.11
Beta
1.16
High GrowthMomentum
vs Healthcare sector:P/E 47 vs 28 Moat 67 vs 7Yield 0.25% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · WST